title: Delta virus and childhood leukemia.
abstract: We studied 145 children with acute lymphocytic leukemia (ALL) in remission who had been off chemotherapy for at least 2 years, to assess the prevalence of hepatitis delta virus (HDV) infection, and to determine whether HDV infection was associated with more severe chronic liver disease. The prevalence of chronic HBV infection was 41.5% (60/145). The prevalence of HDV infection among these patients with chronic HBV infection was 50% (30/60). Eighty-five patients were HBsAg-negative. There was evidence that HDV-infected children had more severe chronic liver disease than did HBsAg-positive, anti-HDV-negative patients: (1) their serum ALT levels were significantly more likely to be elevated at long-term follow-up (27/30 vs. 10/26, p = 0.0001); (2) their mean ALT levels were significantly higher 3 years after the cessation of chemotherapy (128 vs. 84 IU/L, p = 0.001); and (3) they were more likely to have either chronic acute hepatitis or cirrhosis when liver biopsy was done (18/23 vs. 6/18, p = 0.0038). Children who were HBsAg-negative had the lowest alanine aminotransferase (ALT) levels and were least likely to have chronic active hepatitis or cirrhosis (3/31). We conclude that infection with HDV in children with ALL is associated with serious chronic liver disease. In long-term survivors, HDV infection is a major cause of morbidity and an adverse prognostic factor in terms of leukemia-free survival.
authors.affiliation: Department of Pediatrics, University of Padua, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Rossetti
authors.forename: L
authors.initials: L
authors.lastname: Zancan
authors.forename: M G
authors.initials: MG
authors.lastname: Bonato
authors.forename: E
authors.initials: E
authors.lastname: Quaranta
authors.forename: A
authors.initials: A
authors.lastname: Rosolen
authors.forename: M
authors.initials: M
authors.lastname: Rugge
authors.forename: L
authors.initials: L
authors.lastname: Zanesco
mesh_terms: D000914:Antibodies, Viral / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D003699:Hepatitis D / Q000150:complications* / Q000517:prevention & control; D006801:Humans; D008099:Liver / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*
chemical_list: D000914:Antibodies, Viral; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D001219:Aspartate Aminotransferases